Sinopharm Group Co's total assets for Q2 2024 were ¥429.58B, an increase of 4.00% from the previous quarter. SHTDY total liabilities were ¥307.15B for the fiscal quarter, a 5.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.